Sarcoma trials in Austria

In Austria 8 Also abroad 605

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Where
Feldkirch, Innsbruck, Krems An Der Donau, Linz
Age
18 years and over
People
400 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01
Phase 3Taking people
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Where
Graz, Vienna
Age
18 years and over
People
348 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00
Phase 3Taking people
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Where
Graz, Innsbruck, Linz, Salzburg, Vienna
Age
Up to 64 years
People
1,351 worldwide
Run by
GPOH gGmbH
See details and how to join2022-501180-40-00 · EU 2022-501180-40-00
No phaseTaking people
Clinical Applicability of Liquid Biopsy in Chondrosarcoma
Where
Graz
Age
18 years to 99 years
People
60
Run by
Medical University of Graz
See details and how to joinNCT07492823
Phase 1Taking people
International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma
Where
Vienna
People
18 worldwide
Run by
GPOH gGmbH
See details and how to join2024-515245-42-00 · EU 2024-515245-42-00
No phaseTaking people
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Where
Graz
Age
18 years and over
People
100 worldwide
Run by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT06408441
Phase 2/3Taking people
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
Where
Graz, Innsbruck, Linz, Salzburg, Vienna
People
436 worldwide
Run by
The University Of Birmingham
See details and how to join2024-516078-31-00 · EU 2024-516078-31-00
Phase 1/2Taking people
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Where
Graz, Innsbruck, Linz, Salzburg, Vienna
People
1,672 worldwide
Run by
University of Birmingham
See details and how to joinNCT04625907 · EU 2024-510579-40-00